TGN1412--a regulator's perspective

Nat Biotechnol. 2006 May;24(5):493-6. doi: 10.1038/nbt0506-493.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Clinical Trials as Topic / legislation & jurisprudence*
  • Clinical Trials as Topic / standards*
  • Drug Approval*
  • Drug Evaluation, Preclinical*
  • Germany
  • Humans
  • Models, Biological
  • Research*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • TGN-1412